网曝门

Menu

Search

Sections

Home
News
网曝门
Sectors
Themes
Insights
Companies
Events
Reports
Premium Insights
Excellence Awards
Innovation Rankings
Magazine
Newsletters

GlobalData

About us
Advertise With Us
Contact Us

From Our Partners

Connecting healthcare tech with the life sciences industry
Optimizing Cell & Gene Therapy Processes
Collaboration and Expertise in Contract Analytical Chemistry
A new generation of CDMO services
Accelerating Biopharmaceutical Innovation
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
The next chapter of clinical trial services
Putting quality first in the pharma supply chain
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential

News
网曝门
Sections
Latest
Sectors
Sections
Latest
Themes
Sections
Latest
Insights
Sections
Latest
Companies
Sections
Latest
Events
Buy Reports
Newsletters

网曝门

Left

Right

Features
Comment & Opinion
Projects
Data Insights

Data Insights

Filter search results

By Company Name

No Filter Selected

By Disease Name

No Filter Selected

By Drug Name

No Filter Selected

By Themes

No Filter Selected

Showing 2 results out of 2

Data Insights

AL-001 by Alzamend Neuro for Alzheimer's Disease: Likelihood of Approval

AL-001 is under clinical development by Alzamend Neuro and currently in Phase II for Alzheimer's Disease. According to GlobalData, Phase...

Data Insights

AL-001 by Alzamend Neuro for Alzheimer's Disease: Likelihood of Approval

AL-001 is under clinical development by Alzamend Neuro and currently in Phase II for Alzheimer's Disease. According to GlobalData, Phase...

The leading site for news and procurement in the pharmaceutical industry

About us
Advertise with us
License our content
Contact us
Editorial approach
Newsletters

Sitemap

Powered by

© V网曝门 2024

Lost Password Back ⟶
Login
Register

Lost Password?

Registration is disabled.